$66.59
-2.38 (-3.45%)
Performance
1D
—
1W
+11.04%
1M
+5.31%
3M
-10.77%
6M
-13.35%
1Y
-8.27%
YTD
-13.23%
Open$68.95
Previous Close$68.97
Day High$69.60
Day Low$65.95
52W High$90.87
52W Low$58.80
Volume—
Avg Volume925.2K
Market Cap5.38B
P/E Ratio—
EPS$-0.59
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$65.03
Above
SMA 200
$70.56
Below
RSI (14)
65.4
Neutral
Trend
Death Cross
Bearish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+17.1% upside
Current
$66.59
$66.59
Target
$77.98
$77.98
$54.55
$77.98 avg
$125.35
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.76B | 1.17B | 623.61M |
| Net Income | 693.46M | 414.48M | 103.27M |
| Profit Margin | 39.4% | 37.5% | 16.6% |
| EBITDA | 905.80M | 571.47M | 195.81M |
| Free Cash Flow | — | — | 61.49M |
| Rev Growth | +128.3% | +35.3% | +11.8% |
| Debt/Equity | 0.51 | 848.93 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $288.24 | -2.24% | 81.4 | 513.86B |
| AMGN | Amgen Inc | $460.28 | -3.80% | 28.5 | 249.09B |
| GILD | Gilead Sciences Inc | $167.57 | -3.96% | — | 212.04B |
| VRTX | Vertex Pharmaceuticals Inc | $542.50 | -1.19% | 30.6 | 134.77B |
| REGN | Regeneron Pharmaceuticals | $902.90 | -2.98% | 19.5 | 84.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.66 | -2.74% | 28.8 | 23.28B |